Baxter recalls cefazolin injection after cardboard particles detected

Baxter International announced a voluntary nationwide recall of lot LD175708 of its cefazolin in dextrose injection, a single‑dose 100 ml infusion bag.

The recall was prompted by a report that cardboard fragments were present as particulate matter in the solution.

Regulators warned that infused foreign particles could lead to pulmonary emboli, vascular occlusions, phlebitis, immune activation, organ dysfunction, or hemolysis, although no adverse events have been reported.

The product is used intravenously to treat or prevent bacterial infections during surgery.